Nuvation Bio Inc. - Common Stock (NUVB)

Q1 2023 13F Holders as of 3/31/2023

Type / Class
Equity / Common Stock
Shares outstanding
339M
Number of holders
126
Total 13F shares, excl. options
137M
Shares change
-2.06M
Total reported value, excl. options
$228M
Value change
-$4.71M
Number of buys
61
Number of sells
-50
Price
$1.66

Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q1 2023

140 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q1 2023.
Nuvation Bio Inc. - Common Stock (NUVB) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 137M shares of 339M outstanding shares and own 40.53% of the company stock.
Largest 10 shareholders include FMR LLC (32.7M shares), Omega Fund Management, LLC (15.1M shares), EcoR1 Capital, LLC (13.9M shares), BlackRock Inc. (11.2M shares), Deep Track Capital, LP (7.72M shares), VANGUARD GROUP INC (7.2M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.85M shares), BRAIDWELL LP (4.12M shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3.81M shares), and Redmile Group, LLC (3.03M shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.